Navigation Links
Boston College Researchers discover 2 early stages of carbon nanotube growth
Date:10/3/2011

CHESTNUT HILL, MA -- Boston College researchers have discovered two early-stage phases of carbon nanotube growth during plasma enhanced chemical vapor deposition, finding a disorderly tangle of tube growth that ultimately yields to orderly rows of the nanoscopic tubes, according to a report in the latest edition of the journal Nanotechnology.

By using a thin layer of catalyst, Professor of Physics Zhifeng Ren and researcher Dr. Hengzhi Wang discovered two previously overlooked stages of carbon nanotube growth, they report. The method yields a first stage where budding tubes appear randomly entangled, then a second stage of partially aligned tubes, then a third and final stage of tubes in full alignment, which is the standard used by researchers who produce carbon nanotubes for use in a range of materials and biomedical research.

"These growth phases are controlled by the thickness of the catalyst in use," said Wang. "Each stage, it turns out, has its own merit. Each stage has its own purpose."

In plasma enhanced chemical vapor deposition, carbon nanotubes are grown through the repeated accumulation of carbon atoms from the decomposition of gasses upon a catalyst particle, which creates multilayered carbon material on a substrate. Researchers have sought to create neatly aligned rows of millions of carbon nanotubes upon the substrates.

"We didn't know why we were seeing these nanotube configurations," said Ren, among the pioneers in the development of aligned carbon nanotubes. "This is really why you are a scientist. You see a new phenomenon and then you try to understand it."

Ren and Wang say that in the process of achieving the third stage of nanotube growth, the two earlier phases of growth have gone overlooked as each stage is etched away by the next application of plasma. Further masking these early-stage carbon nanotubes is the fact that they are not present when a thick catalyst is used, according to their findings.

The first stage tubes, produced in zero to four minutes, are described as a tangle of random large and small diameter carbon nanotubes. The second stage tubes, created in four to ten minutes, are generally smaller in diameter, but taller and only partially aligned.

Wang says that while these nanotubes are not in neat, orderly rows, they do have the advantage of offer a larger volumetric density and create a larger surface area, which could be an important development in the use of carbon nanotubes in heat transfer in thermal management. A potential application could involve in applying a thin coating of carbon nanotubes to an integrated circuit in order to draw away heat and efficiently cool the device.

After ten minutes of plasma etching, the early stage nanotubes have been washed away and the third stage tubes begin to emerge in tall, ordered rows upon the substrate. At this stage, the tubes themselves are shielded by makeshift "helmets" of catalyst particles, which effectively protect them during the last part of the growth process. Eventually, these last bits of catalyst are etched away as well.


'/>"/>
Contact: Ed Hayward
ed.hayward@bc.edu
617-552-4826
Boston College
Source:Eurekalert

Related biology technology :

1. Building, Validating & Maintaining Controlled Environment Facilities is Focus of Oct. 18th Seminar in Boston Hosted by Microtest Laboratories
2. Boston Scientific Launches Neuromodulation Learning Institute To Enhance Clinical Education For Spinal Cord Stimulation
3. Genethon and Childrens Hospital Boston Get FDA approval for a Wiskott Aldrich Gene Therapy Trial
4. SynapDx Corporation Licenses Autism Diagnostic Discoveries From Childrens Hospital Boston
5. Boston Scientific to Webcast Conference Call Discussing First Quarter 2011 Financial Results
6. Boston College receives W.M. Keck Foundation funding for nanoscale optical microscope
7. Boston Scientific Acquires Intelect Medical
8. Boston Scientific Begins Patient Enrollment in Clinical Trial Assessing Deep Brain Stimulation for Parkinsons Disease
9. Boston College physics professor Willie Padilla receives PECASE award
10. Stryker Announces Definitive Agreement to Acquire the Neurovascular Division of Boston Scientific for $1.5 Billion
11. Access Pharmaceuticals Presents at American Chemical Society Annual Fall Meeting in Boston, MA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Sequenom, Inc. (NASDAQ: ... enabling healthier lives through the development of innovative products ... the United States denied its ... the claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 ... criteria established by the Supreme Court,s Mayo Collaborative Services ...
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica ... in people with peritoneal or pleural mesothelioma. Their findings are the subject of a ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of ...
(Date:6/23/2016)... Md. , June 23, 2016 A person ... from the crime scene to track the criminal down. ... the U.S. Food and Drug Administration (FDA) uses DNA evidence ... Sound far-fetched? It,s not. The FDA ... sequencing to support investigations of foodborne illnesses. Put as simply ...
Breaking Biology Technology:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... --  The Weather Company , an IBM Business (NYSE: ... in which consumers will be able to interact with IBM ... voice or text and receive relevant information about the product ... have long sought an advertising solution that can create a ... and valuable; and can scale across millions of interactions and ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):